Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Completed · Phase 1
Conditions studied: Cholangitis, Sclerosing, Liver Cirrhosis, Biliary
In brief
OBJECTIVES: I. Assess the safety and effectiveness of budesonide in patients with primary sclerosing cholangitis or primary biliary cirrhosis experiencing a suboptimal response to ursodeoxycholic acid. II. Estimate the efficacy of this therapy in these patient groups as a means of evaluating the feasibility of a long-term randomized trial.
Key facts
- Study ID
- NCT00004842
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 22
- Starts
- 1997-05-01
- Expected to finish
- 1999-04-01
- Last updated by the study team
- 2017-05-31
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.